Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (6 ops.)
Latest filing published 23 Jul 2021 for ALEXION PHARMACEUTICALS INC.
Insider track record
Disclosed buys
1
Disclosed sells
6
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Andreas Rummelt: trading record in brief
Andreas Rummelt (board member) discloses dealings in Alexion Pharmaceuticals Inc to SEC (Form 4). We count 29 filings; the first trade dates from 23 February 2010 and the latest from 21 July 2021.
The open-market side counts 1 purchase for €208k alongside 6 sales for €3.1M. Taken together, the sales exceed the purchases by €2.9M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 10 share grants and 11 option exercises.
The newest entry dates from 23 July 2021: a transaction, in Alexion Pharmaceuticals Inc. The latest purchase dates back some time: it was published 6,009 days ago, on 12 May 2010. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Andreas Rummelt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations29 total
28,109 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000064:0
533 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000045:1
1,962 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000045:0
3,468 shares0Common Stock, par value $.0001 per shareSEC:0000899866-20-000049:0
2,726 shares0Common Stock, par value $.0001 per shareSEC:0000899866-19-000066:0
2,174 shares0Common Stock, par value $.0001 per shareSEC:0000899866-18-000092:0
2,030 shares0Common Stock, par value $.0001 per shareSEC:0000899866-17-000114:0
835 shares0Common Stock, par value $.0001 per shareSEC:0000899866-16-000306:0
700 shares0Common Stock, par value $.0001 per shareSEC:0000899866-15-000116:0
3,659 shares@ US$24.36Common Stock, par value $.0001 per shareSEC:0000899866-14-000188:0
1,393 shares@ US$49.43Common Stock, par value $.0001 per shareSEC:0000899866-14-000188:1
5,052 shares@ US$170.53Common Stock, par value $.0001 per shareSEC:0000899866-14-000188:2
895 shares0Common StockSEC:0000899866-14-000089:0
2,471 shares0Common Stock, par value $.0001 per shareSEC:0000899866-13-000042:0
10,000 shares@ US$107.00Common Stock, par value $.0001 per shareSEC:0001231977-12-000061:0
10,000 shares@ US$91.29Common Stock, par value $.0001 per shareSEC:0001231977-12-000056:0
2,786 shares@ US$49.43Common Stock, par value $.0001 per shareSEC:0001231977-12-000032:0
2,786 shares@ US$81.27Common Stock, par value $.0001 per shareSEC:0001231977-12-000032:1
3,657 shares@ US$24.36Common Stock, par value $.0001 per shareSEC:0001231977-12-000032:2
3,657 shares@ US$84.96Common Stock, par value $.0001 per shareSEC:0001231977-12-000032:3
3,115 shares0Common Stock, par value $.0001 per shareSEC:0001231977-12-000018:0
3,656 shares@ US$24.36Common Stock, par value $.0001 per shareSEC:0001231977-11-000076:0
3,966 shares@ US$26.64Common Stock, par value $.0001 per shareSEC:0001231977-11-000076:1
1,393 shares@ US$49.43Common Stock, par value $.0001 per shareSEC:0001231977-11-000076:2
9,015 shares@ US$69.01Common Stock, par value $.0001 per shareSEC:0001231977-11-000076:3
25 of 29 declarations
